Neil Carleton

University Of Pittsburgh At Pittsburgh

$242,965

Attributed

$242,965

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $54K · FY2021–25

$100K$75K$50K$25K$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$242,965 · 1

By mechanism

F30$242,965 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Cytokine Receptors”

Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
Taia Wang · Stanford University$8,138,471
Gary Fanger · Rise Therapeutics, Llc$6,335,320
Zachary Scott Morris · University Of Wisconsin-Madison$6,133,756
Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,759,455
Michael R Ruff · Creative Bio-Peptides, Inc.$5,723,608

Research focus

Cytokine ReceptorsCostAgedCytokineAgingAge RelatedAnti-Inflammatory AgentsBehaviorAdverse EffectsBiologyBreastBreast Cancer Cell LineBreast Cancer ModelBreast Cancer PatientBreast Cancer ProgressionBreast Cancer Risk FactorCancer EtiologyCareerBiologicalChemokineChronicClinical TrialsCohortDeimplementation

Grant awards (5)

Promotion of ER+ Breast Cancer Progression in the Elderly$44,942

F30 · FY2025 · CA · contact PI

Promotion of ER+ Breast Cancer Progression in the Elderly$53,974

F30 · FY2024 · CA · contact PI

Promotion of ER+ Breast Cancer Progression in the Elderly$48,883

F30 · FY2023 · CA · contact PI

Promotion of ER+ Breast Cancer Progression in the Elderly$47,941

F30 · FY2022 · CA · contact PI

Promotion of ER+ Breast Cancer Progression in the Elderly$47,225

F30 · FY2021 · CA · contact PI